E Fund Management Co., Ltd. Roivant Sciences Ltd. Transaction History
E Fund Management Co., Ltd.
- $1.97 Billion
- Q4 2024
A detailed history of E Fund Management Co., Ltd. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 50,647 shares of ROIV stock, worth $532,806. This represents 0.03% of its overall portfolio holdings.
Number of Shares
50,647
Previous 42,112
20.27%
Holding current value
$532,806
Previous $485,000
23.51%
% of portfolio
0.03%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding ROIV
# of Institutions
329Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$692 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$653 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$503 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$464 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$372 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.41B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...